Literature DB >> 11883783

1H, 13C, and 15N resonance assignment of the vascular endothelial growth factor receptor-binding domain in complex with a receptor-blocking peptide.

Borlan Pan, Wayne J Fairbrother.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11883783     DOI： 10.1023/a:1014297525543

Source DB:  PubMed          Journal:  J Biomol NMR        ISSN： 0925-2738            Impact factor:   2.835


× No keyword cloud information.
  9 in total

1.  Characterization of the binding interface between the E-domain of Staphylococcal protein A and an antibody Fv-fragment.

Authors:  D P Meininger; M Rance; M A Starovasnik; W J Fairbrother; N J Skelton
Journal:  Biochemistry       Date:  2000-01-11       Impact factor: 3.162

Review 2.  Role of vascular endothelial growth factor in regulation of physiological angiogenesis.

Authors:  N Ferrara
Journal:  Am J Physiol Cell Physiol       Date:  2001-06       Impact factor: 4.249

3.  Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site.

Authors:  Y A Muller; B Li; H W Christinger; J A Wells; B C Cunningham; A M de Vos
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

4.  The program XEASY for computer-supported NMR spectral analysis of biological macromolecules.

Authors:  C Bartels; T H Xia; M Billeter; P Güntert; K Wüthrich
Journal:  J Biomol NMR       Date:  1995-07       Impact factor: 2.835

5.  Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor.

Authors:  C Wiesmann; G Fuh; H W Christinger; C Eigenbrot; J A Wells; A M de Vos
Journal:  Cell       Date:  1997-11-28       Impact factor: 41.582

6.  1H, 13C, and 15N backbone assignment and secondary structure of the receptor-binding domain of vascular endothelial growth factor.

Authors:  W J Fairbrother; M A Champe; H W Christinger; B A Keyt; M A Starovasnik
Journal:  Protein Sci       Date:  1997-10       Impact factor: 6.725

Review 7.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

8.  Novel peptides selected to bind vascular endothelial growth factor target the receptor-binding site.

Authors:  W J Fairbrother; H W Christinger; A G Cochran; G Fuh; C J Keenan; C Quan; S K Shriver; J Y Tom; J A Wells; B C Cunningham
Journal:  Biochemistry       Date:  1998-12-22       Impact factor: 3.162

9.  Crystal structure of the complex between VEGF and a receptor-blocking peptide.

Authors:  C Wiesmann; H W Christinger; A G Cochran; B C Cunningham; W J Fairbrother; C J Keenan; G Meng; A M de Vos
Journal:  Biochemistry       Date:  1998-12-22       Impact factor: 3.162
  9 in total
  3 in total

1.  A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF165.

Authors:  Joon-Hwa Lee; Marella D Canny; Andrea De Erkenez; Dominik Krilleke; Yin-Shan Ng; David T Shima; Arthur Pardi; Fiona Jucker
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-15       Impact factor: 11.205

2.  Dimerization of VEGF receptors and implications for signal transduction: a computational study.

Authors:  Feilim Mac Gabhann; Aleksander S Popel
Journal:  Biophys Chem       Date:  2007-03-24       Impact factor: 2.352

Review 3.  A Structural Overview of Vascular Endothelial Growth Factors Pharmacological Ligands: From Macromolecules to Designed Peptidomimetics.

Authors:  Xiaoqing Ye; Jean-François Gaucher; Michel Vidal; Sylvain Broussy
Journal:  Molecules       Date:  2021-11-09       Impact factor: 4.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.